Pasithea Therapeutics Postpones Special Meeting
Miami Beach, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE)
Introduction
Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (“CNS”) disorders, announced that it has postponed its Special Stockholder Meeting originally scheduled for November 29, 2022.
Reason for Postponement
The Company stated that the Special Meeting has been rescheduled to December 9, 2022, at 9:00 AM Eastern Time to allow for additional time for preparations and deliberations. Pasithea Therapeutics aims to provide the most comprehensive and accurate information to its stockholders before the meeting takes place.
Impact on Stockholders
This postponement may cause some uncertainty and speculation among stockholders, but it also demonstrates the Company’s commitment to transparency and thorough decision-making processes. Stockholders are encouraged to stay informed through official channels and updates provided by Pasithea Therapeutics.
Effect on Individuals
As an individual investor in Pasithea Therapeutics, this postponement may affect your plans and expectations regarding the Special Meeting. It is important to stay updated on any developments and announcements from the Company to make informed decisions regarding your investment.
Global Implications
On a larger scale, the postponement of Pasithea Therapeutics’ Special Meeting may impact the biotechnology industry and investor confidence. The Company’s actions and decisions could have ripple effects in the global market, influencing trends and sentiments in the healthcare sector.
Conclusion
In conclusion, Pasithea Therapeutics’ decision to postpone its Special Stockholder Meeting reflects a dedication to thoroughness and transparency in its operations. Stockholders should stay informed and patient as the Company prepares for the rescheduled meeting, while also considering the broader implications this delay may have on the industry and global market.
